Rapamycin is a neuroprotective treatment for traumatic brain injury

Neurobiology of Disease

Volumn 26, Issue 1, 2007, Pages 86-93

  Erlich, S ^a   Alexandrovich, A ^b   Shohami, E ^b   Pinkas Kramarski, R ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Autophagy; Beclin 1; Brain; Closed head injury; Neurons; Rapamycin

Indexed keywords

GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL CYCLE ARREST; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUROLOGICAL SEVERITY SCORE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; RATING SCALE; TRANSLATION REGULATION; TRAUMATIC BRAIN INJURY;

ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; BRAIN CHEMISTRY; BRAIN INJURIES; CELL SURVIVAL; FUNCTIONAL LATERALITY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEUROPROTECTIVE AGENTS; PROTEIN KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 33947219280     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.12.003     Document Type: Article

References (44)

1. Baker H., Sidorowicz A., Sehgal S.N., and Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation. J. Antibiot. 31 (1978) 539-545
2. Beni-Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., Eizenberg O., Trembolver V., and Shohami E. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 298 (2001) 57-63
3. Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O'Kane C.J., and Rubinsztein D.C. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15 (2006) 433-442
4. Blommaart E.F., Luiken J.J., Blommaart P.J., vanWoerkom G.M., and Meijer A.J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270 (1995) 2320-2326
5. Chen Y., Constantini S., Trembovler V., Weinstock M., and Shohami E. An experimental model of closed head injury in mice: pathophysiology, histopathology and cognitive deficits. J. Neurotrauma 13 (1996) 557-568
6. Diskin T., Tal-Or P., Erlich S., Mizrachy L., Alexandrovich A., Shohami E., and Pinkas-Kramarski R. Closed head injury induces upregulation of beclin 1 at the cortical site of injury. J. Neurotrauma 22 (2005) 750-762
7. Dutcher J.P. Mammalian target of rapamycin inhibition. Clin Cancer Res. 10 (2004) 6382S-6387S
8. Erlich S., Shohami E., and Pinkas-Kramarski R. Closed head injury induces upregulation of ErbB-4 receptor at the site of injury. Mol. Cell. Neurosci. 16 (2000) 597-608
9. Erlich S., Shohami E., and Pinkas-Kramarski R. Neurodegeneration induces up regulation Beclin 1. Autophagy 2 (2006) e4-e6
10. Faden A.I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7 (1993) 175-186
11. Giulian D. Microglia and inflammatory response. In: Welch K.M.A., Caplan L.R., Reis D.J., Siesjo B.K., and Weir B. (Eds). Primer on Cerebrovascular Disease (1997), Academic Press, San Diego, CA 117-124
12. Guba M., von Breitenbuch P., Steinbauer M., Koehl G., Flegel S., Hornung M., Bruns C.J., Zuelke C., Farkas S., Anthuber M., Jauch K.W., and Geissler E.K. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat. Med. 8 (2002) 128-135
13. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., and Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
14. Harris T.E., and Lawrence J.C.J. TOR signaling. Sci STKE. (2003) re15
15. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev. (2004) 1926-1945
16. Kamada Y., Sekito T., and Ohsumi Y. Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr. Top. Microbiol. Immunol. 279 (2004) 73-84
17. Kihara A., Kabeya Y., Ohsumi Y., and Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2 (2001) 325-330
18. Kirino T. Delayed neuronal death. Neuropathology 20 (2000) S95-S97
19. Klionsky D.J., and Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
20. Koehl G.E., Andrassy J., Guba M., Richter S., Kroemer A., Scherer M.N., Steinbauer M., Graeb C., Schlitt H.J., Jauch K.W., and Geissler E.K. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 77 (2004) 1319-1326
21. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J.I., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., and Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
22. Larsen K.E., and Sulzer D. Autophagy in neurons: a review. Histol. Histopathol. 17 (2002) 897-908
23. Leker R.R., and Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 39 (2002) 55-73
24. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., and Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402 (1999) 672-676
25. Majumder P.K., Febbo P.G., Bikoff R., Berger R., Xue Q., McMahon L.M., Manola J., Brugarolas J., McDonnell T.J., Golub T.R., Loda M., Lane H.A., and Sellers W.R. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10 (2004) 594-601
26. Martel R.R., Klicius J., and Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J. Physiol. Pharmacol. 55 (1977) 48-51
27. Noda T., and Ohsumi Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273 (1998) 3963-3966
28. Ogier-Denis E., and Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim. Biophys. Acta 603 (2003) 113-128
29. Olsen T.W., Benegas N.M., Joplin A.C., Evangelista T., Mindrup E.A., and Holland E.J. Rapamycin inhibits corneal allograft rejection and neovascularization. Arch. Ophthalmol. 112 (1994) 1471-1475
30. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
31. Pinkas-Kramarski R., Eilam R., Alroy I., Levkowitz G., Lonai P., and Yarden Y. Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation. Oncogene 15 (1997) 2803-2815
32. Proud C.G. mTOR-mediated regulation of translation factors by amino acids. Biochem. Biophys. Res. Commun. 313 (2004) 429-436
33. Ravikumar B., and Rubinsztein D.C. Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?. NeuroReport 15 (2004) 2443-2445
34. Ravikumar B., Duden R., and Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11 (2002) 1107-1117
35. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G.F., Easton D.F., Duden R., O'Kane C.J., and Rubinsztein D.C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36 (2004) 585-595
36. Reggiori F., and Klionsky D.J. Autophagy in the eukaryotic cell. Eukaryot. Cell 1 (2002) 11-21
37. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
38. Shigemitsu K., Tsujishita Y., Hara K., Nanahoshi M., Avruch J., and Yonezawa K. Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells. J. Biol. Chem. 274 (1999) 1058-1065
39. Shohami E., Ginis I., and Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10 (1999) 119-130
40. Sousa J.E., Sousa A.G., Costa M.A., Abizaid A.C., and Feres F. Use of rapamycin-impregnated stents in coronary arteries. Transplant. Proc. 35 (2003) 165S-170S
41. Vignot S., Faivre S., Aguirre D., and Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16 (2005) 525-537
42. Wang C.W., and Klionsky D.J. The molecular mechanism of autophagy. Mol. Med. 9 (2003) 65-76
43. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubin-Sztein D. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278 (2003) 25009-25013
44. Yatsiv I., Grigoriadis N., Simeonidou C., Stahel P.F., Schmidt O.I., Alexandrovitch A.G., Tsenter J., and Shohami E. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 12 (2005) 1701-1703